Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication
about
Developing Combined HIV Vaccine Strategies for a Functional CureSAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesisHumoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV InfectionAdvancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates.Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition.Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.Evaluation of a multiplex assay for estimation of HIV-1 incidence.Vaccines that stimulate T cell immunity to HIV-1: the next stepIdentification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques.The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids.Future of phylogeny in HIV prevention.Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesEarly Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventionsBroad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.Dynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus InfectionRelative resistance of HIV-1 founder viruses to control by interferon-alpha.Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection.High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.Complex correlates of protection after vaccination.Kill: boosting HIV-specific immune responses.Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infectionInsights into the Impact of CD8+ Immune Modulation on Human Immunodeficiency Virus Evolutionary Dynamics in Distinct Anatomical Compartments by Using Simian Immunodeficiency Virus-Infected Macaque Models of AIDS Progression.NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.Acute Human Immunodeficiency Virus (HIV) Infection Presenting With Bilateral Interstitial Pneumonia: Case Report and Discussion of Potential HIV-Induced Interstitial Pneumonia.Differentiation and Function of Follicular CD8 T Cells During Human Immunodeficiency Virus Infection.Phenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection
P2860
Q26998898-01AB3E2C-89FC-4F81-91AE-2C37FB32E438Q27321665-DF633706-6724-40AC-BF3D-B4B9466488EBQ30432007-570EDD57-333D-457A-A7EF-E26AD960361BQ33620546-7D35166A-8836-4E0A-9500-F422031025EBQ33742529-7C46D916-29D8-4EA0-9BEB-B527E4BC1A1CQ34059178-9B375398-2611-49E6-9D3C-A8764A878AD8Q34059605-76B044B3-5D3E-4A54-9DF5-0D058F8459E3Q34423446-A2DBBDFC-2D16-4E61-8041-2356A998CAC8Q34535266-D8812420-5374-4CC2-A535-3DBADE439A08Q34745421-BE407A92-32D4-49EB-9148-AEFAB5802E4EQ35073079-E0AABF17-5253-4970-84C8-2D5188FE185AQ35130519-69BDF6B6-E1A4-4E3F-8CCF-EC73512EEE4AQ35593139-BD508B5E-4989-4250-871B-234CF22C196FQ35739841-B792017A-977A-464E-8AAA-2AE6CA5DEE5CQ35836048-044EBE40-9EB6-4743-8D9B-D61C6888D499Q36018536-4CF519A9-4E2A-46CF-8331-BAEE543855E8Q36945699-93F93E60-78E1-4E40-9AC2-F4849DD6EE93Q36951283-0C5D73E5-1173-4963-8C11-DB7B03DF3A0AQ36978671-0243489C-0862-4881-AB37-1A704DB66C75Q36978926-DEEC6D71-FDE6-4761-9593-0974A384E408Q37206422-938BF6C0-23B0-4834-B1C4-A05D4B42CC05Q37221660-CB625BB7-A90E-48C5-A82F-694EBB64E9D8Q37252772-09EAF82A-D400-4759-986C-1DBC6BC566D7Q37532983-D7208231-3978-4E35-BEC1-5D1D30EC3EF4Q37548329-73773133-75DC-48D4-B0EB-495A8FBCC56FQ38184579-52608B53-7EE0-4492-9877-A7484CCD68C9Q38433251-F1DCB0DA-3422-47B1-85AD-E49110F0BDFDQ38433342-82CCB1D0-278C-48CD-A186-DCA6FDAB949CQ38456515-7B8D2E75-77B0-43CF-8312-45531D183D4CQ38800533-CA627827-9CBE-4BA3-997D-6841E4F38F56Q40615883-142C5437-42BD-408B-B439-8BC72ACF7095Q41857492-7258C08A-FC76-44A0-AA98-C6D5A2BFB9F9Q41933419-69AE4F57-4647-4F68-AF49-8FA738391086Q44766920-2FF94FA3-C005-43AE-9080-33E95A12D7ADQ47123314-9E417EDB-1BA7-4CBE-9AA2-AA5E98D6C8CFQ55365295-6C739FA8-DAF0-48A6-B316-CF32A48AB210Q58572549-31ECD5AF-DA37-45C1-B72B-6A6DBB8FB200
P2860
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Initial HIV-1 antigen-specific ...... tted/founder virus replication
@ast
Initial HIV-1 antigen-specific ...... tted/founder virus replication
@en
type
label
Initial HIV-1 antigen-specific ...... tted/founder virus replication
@ast
Initial HIV-1 antigen-specific ...... tted/founder virus replication
@en
prefLabel
Initial HIV-1 antigen-specific ...... tted/founder virus replication
@ast
Initial HIV-1 antigen-specific ...... tted/founder virus replication
@en
P2093
P2860
P50
P356
P1433
P1476
Initial HIV-1 antigen-specific ...... tted/founder virus replication
@en
P2093
Andrew J McMichael
Christina Ochsenbauer
Coleen K Cunningham
Georgia D Tomaras
Haitao Ding
Jennifer L Kirchherr
John A Crump
John C Kappes
Kelly A Soderberg
Kent J Weinhold
P2860
P304
P356
10.1128/JVI.00437-12
P407
P577
2012-04-18T00:00:00Z